ADAGRASIB vs ADALIMUMAB-AACF: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ADAGRASIB vs ADALIMUMAB-AACF: Safety Overview
| Metric | ADAGRASIB | ADALIMUMAB-AACF |
|---|---|---|
| Total FAERS Reports | 899 | 140 |
| Deaths Reported | 315 | 1 |
| Death Rate | 35.0% | 0.7% |
| Hospitalizations | 350 | 63 |
| Average Patient Age | 68.3 yrs | 54.6 yrs |
| % Female Patients | 56.4% | 60.5% |
| FDA Approval Date | Dec 12, 2022 | N/A |
| Manufacturer | Mirati Therapeutics, Inc | Fresenius Kabi USA, LLC |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |